531 related articles for article (PubMed ID: 31053084)
21. Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.
Haeberle H; Prohaska S; Martus P; Straub A; Zarbock A; Marx G; Zago M; Giera M; Koeppen M; Rosenberger P
Trials; 2020 Mar; 21(1):242. PubMed ID: 32131881
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin in the acute respiratory distress syndrome.
McAuley DF; Laffey JG; O'Kane CM; Perkins GD; Mullan B; Trinder TJ; Johnston P; Hopkins PA; Johnston AJ; McDowell C; McNally C; ;
N Engl J Med; 2014 Oct; 371(18):1695-703. PubMed ID: 25268516
[TBL] [Abstract][Full Text] [Related]
23. Association of gender with outcomes in critically ill patients.
Mahmood K; Eldeirawi K; Wahidi MM
Crit Care; 2012 May; 16(3):R92. PubMed ID: 22617003
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-146b correlates with decreased acute respiratory distress syndrome risk, reduced disease severity, and lower 28-day mortality in sepsis patients.
Chen W; Liu L; Yang J; Wang Y
J Clin Lab Anal; 2020 Dec; 34(12):e23510. PubMed ID: 32845540
[TBL] [Abstract][Full Text] [Related]
25. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial.
Fowler AA; Truwit JD; Hite RD; Morris PE; DeWilde C; Priday A; Fisher B; Thacker LR; Natarajan R; Brophy DF; Sculthorpe R; Nanchal R; Syed A; Sturgill J; Martin GS; Sevransky J; Kashiouris M; Hamman S; Egan KF; Hastings A; Spencer W; Tench S; Mehkri O; Bindas J; Duggal A; Graf J; Zellner S; Yanny L; McPolin C; Hollrith T; Kramer D; Ojielo C; Damm T; Cassity E; Wieliczko A; Halquist M
JAMA; 2019 Oct; 322(13):1261-1270. PubMed ID: 31573637
[TBL] [Abstract][Full Text] [Related]
26. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.
Dinglas VD; Hopkins RO; Wozniak AW; Hough CL; Morris PE; Jackson JC; Mendez-Tellez PA; Bienvenu OJ; Ely EW; Colantuoni E; Needham DM
Thorax; 2016 May; 71(5):401-10. PubMed ID: 26936876
[TBL] [Abstract][Full Text] [Related]
27. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
Bagshaw SM; Chawla LS
Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
[TBL] [Abstract][Full Text] [Related]
28. The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis.
Angus DC; Laterre PF; Helterbrand J; Ely EW; Ball DE; Garg R; Weissfeld LA; Bernard GR;
Crit Care Med; 2004 Nov; 32(11):2199-206. PubMed ID: 15640631
[TBL] [Abstract][Full Text] [Related]
29. Levosimendan does not reduce the mortality of critically ill adult patients with sepsis and septic shock: a meta-analysis.
Feng F; Chen Y; Li M; Yuan JJ; Chang XN; Dong CM
Chin Med J (Engl); 2019 May; 132(10):1212-1217. PubMed ID: 31140992
[TBL] [Abstract][Full Text] [Related]
30. Severity of illness and risk of death associated with pulmonary artery catheter use.
Chittock DR; Dhingra VK; Ronco JJ; Russell JA; Forrest DM; Tweeddale M; Fenwick JC
Crit Care Med; 2004 Apr; 32(4):911-5. PubMed ID: 15071376
[TBL] [Abstract][Full Text] [Related]
31. Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients.
Jensen JS; Peters L; Itenov TS; Bestle M; Thormar KM; Mohr TT; Lundgren B; Grarup J; Lundgren JD;
Clin Chem Lab Med; 2019 Aug; 57(9):1422-1431. PubMed ID: 30951497
[TBL] [Abstract][Full Text] [Related]
32. Preadmission Oral Corticosteroids Are Associated With Reduced Risk of Acute Respiratory Distress Syndrome in Critically Ill Adults With Sepsis.
McKown AC; McGuinn EM; Ware LB; Wang L; Janz DR; Rice TW; Semler MW
Crit Care Med; 2017 May; 45(5):774-780. PubMed ID: 28257336
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
Hummel J; Rücker G; Stiller B
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011312. PubMed ID: 28262914
[TBL] [Abstract][Full Text] [Related]
34. Statins in patients with sepsis and ARDS: is it over? We are not sure.
McAuley D; Charles PE; Papazian L
Intensive Care Med; 2017 May; 43(5):677-679. PubMed ID: 27752736
[No Abstract] [Full Text] [Related]
35. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).
Chacko B; Peter JV; Tharyan P; John G; Jeyaseelan L
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008807. PubMed ID: 25586462
[TBL] [Abstract][Full Text] [Related]
36. Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsis.
Macias WL; Vallet B; Bernard GR; Vincent JL; Laterre PF; Nelson DR; Derchak PA; Dhainaut JF
Crit Care Med; 2004 Dec; 32(12):2385-91. PubMed ID: 15599140
[TBL] [Abstract][Full Text] [Related]
37. Corticosteroids for treating sepsis.
Annane D; Bellissant E; Bollaert PE; Briegel J; Keh D; Kupfer Y
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD002243. PubMed ID: 26633262
[TBL] [Abstract][Full Text] [Related]
38. A comparative analysis of sivelestat sodium hydrate and ulinastatin combination therapy in the treatment of sepsis with acute respiratory distress syndrome.
Xu J; Zhang C; Wu K; Qian Y; Hu W
BMC Pulm Med; 2024 Jun; 24(1):283. PubMed ID: 38886709
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
Sinha P; Calfee CS; Cherian S; Brealey D; Cutler S; King C; Killick C; Richards O; Cheema Y; Bailey C; Reddy K; Delucchi KL; Shankar-Hari M; Gordon AC; Shyamsundar M; O'Kane CM; McAuley DF; Szakmany T
Lancet Respir Med; 2020 Dec; 8(12):1209-1218. PubMed ID: 32861275
[TBL] [Abstract][Full Text] [Related]
40. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.
Sinha P; Kerchberger VE; Willmore A; Chambers J; Zhuo H; Abbott J; Jones C; Wickersham N; Wu N; Neyton L; Langelier CR; Mick E; He J; Jauregui A; Churpek MM; Gomez AD; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Delucchi KL; Liu KD; Russell JA; Matthay MA; Walley KR; Ware LB; Calfee CS
Lancet Respir Med; 2023 Nov; 11(11):965-974. PubMed ID: 37633303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
